Medifron DBT Co., Ltd. (KOSDAQ:A065650) announced private placement of 4,512,635 shares at a price of KRW 3,324 per share for gross proceeds of KRW 14,999,998,740 with new investor T Scientific Co., Ltd. (KOSDAQ:A057680) on December 30, 2020. The investor will acquire 10.82% stake in the company. The shares are subject to hold period of 1 year.

The expected payment date is February 5, 2021. The transaction is approved by the board of directors of the company.